BBVLX | RMEBX | BBVLX / RMEBX | |
Total Expense Ratio | 0.24 | 1.07 | 22% |
Annual Report Gross Expense Ratio | 0.46 | 1.07 | 43% |
Fund Existence | 10 years | 11 years | - |
Gain YTD | 10.032 | 14.848 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.7B | 113B | 23% |
Annual Yield % from dividends | 1.73 | 1.05 | 164% |
Returns for 1 year | 2.77 | 7.71 | 36% |
Returns for 3 years | 35.31 | 43.29 | 82% |
Returns for 5 years | 56.49 | 57.72 | 98% |
Returns for 10 years | 130.91 | 92.43 | 142% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GIAX | 17.80 | 0.09 | +0.51% |
Nicholas Global Equity and Income ETF | |||
GLOF | 52.00 | 0.21 | +0.40% |
iShares Global Equity Factor ETF | |||
BTR | 25.23 | N/A | N/A |
Beacon Tactical Risk ETF | |||
IHE | 75.18 | -0.02 | -0.03% |
iShares US Pharmaceuticals ETF | |||
SHYG | 43.00 | -0.05 | -0.12% |
iShares 0-5 Year High Yield Corp Bd ETF |